ID

29225

Descripción

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide; ODM derived from: https://clinicaltrials.gov/show/NCT00696657

Link

https://clinicaltrials.gov/show/NCT00696657

Palabras clave

Versiones (1)
  1. 9/3/18 9/3/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

9 de marzo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT00696657

Inglés

Eligibility Diabetes NCT00696657

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00696657
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women-not-of-childbearing potential diagnosed with type 2 diabetes for at least three months
Descripción

Gender | Childbearing Potential Absent | Non-Insulin-Dependent Diabetes Mellitus Disease length

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0011860
UMLS CUI [3,2]
C0872146
stable treatment regimen with either metformin (at least 1500 mg) or diet and exercise alone for at least three months
Descripción

Metformin Dose Stable | Diet therapy | Exercise

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
hba1c: 7.0-10.0 % (both inclusive)
Descripción

Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202054
body weight between 60 kg and 110 kg
Descripción

Body Weight

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005910
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with insulin, glp-1 receptor agonists (including liraglutide), dipeptidyl peptidase-4 inhibitors, sulphonylurea, thiazolidinediones, alpha-gis, or any investigational drug, within the last three months
Descripción

Insulin | GLP-1 Receptor Agonist | liraglutide | Dipeptidyl Peptidase 4 Inhibitors | Sulfonylurea | Thiazolidinediones | alpha-Glucosidase Inhibitors | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C2917359
UMLS CUI [3]
C1456408
UMLS CUI [4]
C2917254
UMLS CUI [5]
C0038766
UMLS CUI [6]
C1257987
UMLS CUI [7]
C1299007
UMLS CUI [8]
C0013230
impaired liver or kidney function
Descripción

Liver Dysfunction | Renal Insufficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
proliferative retinopathy or maculopathy requiring acute treatment
Descripción

Proliferative retinopathy Treatment required for | Disorder of macula of retina Treatment required for

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0339467
UMLS CUI [1,2]
C0332121
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C0332121
clinically significant active cardiovascular disease and uncontrolled treated/untreated hypertension
Descripción

Cardiovascular Disease | Uncontrolled hypertension Treated | Uncontrolled hypertension untreated

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C1868885
UMLS CUI [3,2]
C0332155
recurrent major hypoglycaemia or hypoglycaemic unawareness
Descripción

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
present or planned use of any drug which could interfere with the glucose levels (e.g. systemic corticosteroids)
Descripción

Pharmaceutical Preparations Interfere with Glucose level | CORTICOSTEROIDS FOR SYSTEMIC USE

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0428548
UMLS CUI [2]
C3653708
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT00696657

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00696657
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Childbearing Potential Absent | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
men and women-not-of-childbearing potential diagnosed with type 2 diabetes for at least three months
boolean
C0079399 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0011860 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
Metformin Dose Stable | Diet therapy | Exercise
Item
stable treatment regimen with either metformin (at least 1500 mg) or diet and exercise alone for at least three months
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
Glucohemoglobin measurement
Item
hba1c: 7.0-10.0 % (both inclusive)
boolean
C0202054 (UMLS CUI [1])
Body Weight
Item
body weight between 60 kg and 110 kg
boolean
C0005910 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin | GLP-1 Receptor Agonist | liraglutide | Dipeptidyl Peptidase 4 Inhibitors | Sulfonylurea | Thiazolidinediones | alpha-Glucosidase Inhibitors | Investigational New Drugs
Item
treatment with insulin, glp-1 receptor agonists (including liraglutide), dipeptidyl peptidase-4 inhibitors, sulphonylurea, thiazolidinediones, alpha-gis, or any investigational drug, within the last three months
boolean
C0021641 (UMLS CUI [1])
C2917359 (UMLS CUI [2])
C1456408 (UMLS CUI [3])
C2917254 (UMLS CUI [4])
C0038766 (UMLS CUI [5])
C1257987 (UMLS CUI [6])
C1299007 (UMLS CUI [7])
C0013230 (UMLS CUI [8])
Liver Dysfunction | Renal Insufficiency
Item
impaired liver or kidney function
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Proliferative retinopathy Treatment required for | Disorder of macula of retina Treatment required for
Item
proliferative retinopathy or maculopathy requiring acute treatment
boolean
C0339467 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0730362 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
Cardiovascular Disease | Uncontrolled hypertension Treated | Uncontrolled hypertension untreated
Item
clinically significant active cardiovascular disease and uncontrolled treated/untreated hypertension
boolean
C0007222 (UMLS CUI [1])
C1868885 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C1868885 (UMLS CUI [3,1])
C0332155 (UMLS CUI [3,2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Pharmaceutical Preparations Interfere with Glucose level | CORTICOSTEROIDS FOR SYSTEMIC USE
Item
present or planned use of any drug which could interfere with the glucose levels (e.g. systemic corticosteroids)
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0428548 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial